首页 | 本学科首页   官方微博 | 高级检索  
检索        


Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer
Authors:Guru Sonpavde MD  Neeraj Agarwal MD  Gregory Russell Pond PhD  Rebecca J Nagy MSc  Roberto H Nussenzveig PhD  Andrew W Hahn MD  Oliver Sartor MD  Theodore Stewart Gourdin MD  Lakshminarayanan Nandagopal MD  Elisa M Ledet PhD  Gurudatta Naik MPH  Andrew J Armstrong MD  MSc  Jue Wang MD  Mehmet Asim Bilen MD  Shilpa Gupta MD  Petros Grivas MD  PhD  Sumanta K Pal MD  Richard B Lanman MD  AmirAli Talasaz PhD  Michael B Lilly MD
Institution:1. Dana-Farber Cancer Institute, Boston, Massachusetts;2. Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah;3. Ontario Clinical Oncology Group, Hamilton, Ontario, Canada;4. Guardant Health Inc, Redwood City, California;5. Tulane University, New Orleans, Louisiana;6. Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina;7. University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama;8. Duke Cancer Center, Durham, North Carolina;9. University of Arizona Cancer Center at Dignity Health St. Joseph’s Hospital and Medical Center, Phoenix, Arizona;10. Winship Cancer Institute, Emory University, Atlanta, Georgia;11. University of Minnesota, Minneapolis, Minnesota;12. University of Washington, Seattle, Washington;13. City of Hope Comprehensive Cancer Center, Duarte, California
Abstract:
Keywords:castration resistant  circulating tumor DNA (ctDNA)  failure-free survival  genomic profiling  metastatic  prostate cancer  survival
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号